
The Impact of IL-13 Inhibition as a Treatment Option for Adult Patients with Moderate-to-Severe Atopic Dermatitis
Sponsored by

Summary:
Join us as we review the role of IL-13 in the pathophysiology of atopic dermatitis and discuss a treatment option for adults with moderate-to-severe atopic dermatitis.
Objectives:
-
Review the role of IL-13 in the pathophysiology of atopic dermatitis
-
Discuss the impact of IL-13 inhibition as a treatment option for adult patients with moderate-to-severe atopic dermatitis.
Log In
If you are already registered, look up the email address you used to register to log in below.Presenter
- Mona Shahriari, MDAssistant Clinical Professor of Dermatology Yale University School of MedicineNew Haven, CTCentral Connecticut DermatologyCromwell, CT